{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T06:10:06Z","timestamp":1751609406747,"version":"3.41.0"},"reference-count":36,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T00:00:00Z","timestamp":1751587200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"DOI":"10.3389\/fcvm.2025.1574521","type":"journal-article","created":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T05:28:42Z","timestamp":1751606922000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Ghrelin peptide in heart failure: when is showtime?"],"prefix":"10.3389","volume":"12","author":[{"given":"Som P.","family":"Singh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anand","family":"Chockalingam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,7,4]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/j.molmet.2015.03.005","article-title":"Ghrelin","volume":"4","author":"M\u00fcller","year":"2015","journal-title":"Mol Metab"},{"key":"B2","doi-asserted-by":"publisher","first-page":"539","DOI":"10.3748\/wjg.v25.i5.539","article-title":"Contribution of ghrelin to functional gastrointestinal disorders\u2019 pathogenesis","volume":"25","author":"Koutouratsas","year":"2019","journal-title":"World J Gastroenterol"},{"key":"B3","article-title":"Biochemistry, Ghrelin. 2023 Jul 17","volume-title":"StatPearls","author":"Young","year":"2025"},{"key":"B4","doi-asserted-by":"publisher","first-page":"518909","DOI":"10.1155\/2013\/518909","article-title":"Structure and physiological actions of ghrelin","volume":"2013","author":"Delporte","year":"2013","journal-title":"Scientifica (Cairo)"},{"key":"B5","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.jjcc.2011.11.002","article-title":"Ghrelin and cardiovascular diseases","volume":"59","author":"Kishimoto","year":"2012","journal-title":"J Cardiol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1111\/cen.15196","article-title":"Ghrelin: an emerging therapy for heart failure","volume":"102","author":"Theodorakis","year":"2025","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B7","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.cardiores.2004.01.024","article-title":"Growth hormone releasing peptide (Ghrelin) is synthesized and secreted by cardiomyocytes","volume":"62","author":"Iglesias","year":"2004","journal-title":"Cardiovasc Res"},{"key":"B8","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.cjco.2020.10.015","article-title":"Regional differences in the Ghrelin-growth hormone secretagogue receptor signalling system in human heart disease","volume":"3","author":"Sullivan","year":"2020","journal-title":"CJC Open"},{"key":"B9","doi-asserted-by":"publisher","first-page":"3803","DOI":"10.1210\/jcem.85.10.6846","article-title":"Growth hormone secretagogue binding sites in peripheral human tissues","volume":"85","author":"Papotti","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"B10","doi-asserted-by":"publisher","first-page":"3426","DOI":"10.1210\/en.2012-1065","article-title":"Ghrelin prevents incidence of malignant arrhythmia after acute myocardial infarction through vagal afferent nerves","volume":"153","author":"Mao","year":"2012","journal-title":"Endocrinology"},{"key":"B11","doi-asserted-by":"publisher","first-page":"E311","DOI":"10.1152\/ajpendo.00123.2013","article-title":"Desacyl ghrelin prevents doxorubicin-induced myocardial fibrosis and apoptosis via the GHSR-independent pathway","volume":"306","author":"Pei","year":"2014","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"B12","doi-asserted-by":"publisher","first-page":"29060","DOI":"10.3390\/ijms161226147","article-title":"Use of inotropic agents in treatment of systolic heart failure","volume":"16","author":"Tariq","year":"2015","journal-title":"Int J Mol Sci"},{"key":"B13","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1002\/ejhf.2814","article-title":"Inotropic therapy in patients with advanced heart failure. A clinical consensus statement from the heart failure association of the European Society of Cardiology","volume":"25","author":"Gustafsson","year":"2023","journal-title":"Eur J Heart Fail"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1161\/CIRCULATIONAHA.109.899294","article-title":"Role of inotropic agents in the treatment of heart failure","volume":"121","author":"Goldhaber","year":"2010","journal-title":"Circulation"},{"key":"B15","doi-asserted-by":"publisher","first-page":"5854","DOI":"10.1210\/jcem.86.12.8115","article-title":"Hemodynamic, renal, and hormonal effects of ghrelin infusion in patients with chronic heart failure","volume":"86","author":"Nagaya","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"B16","doi-asserted-by":"publisher","first-page":"2009","DOI":"10.1093\/eurheartj\/ehad100","article-title":"Acyl ghrelin improves cardiac function in heart failure and increases fractional shortening in cardiomyocytes without calcium mobilization","volume":"44","author":"Lund","year":"2023","journal-title":"Eur Heart J"},{"key":"B17","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/S0033-0620(05)80005-2","article-title":"Electrophysiologic and proarrhythmic effects of intravenous inotropic agents","volume":"38","author":"Tisdale","year":"1995","journal-title":"Prog Cardiovasc Dis"},{"key":"B18","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/s0008-6363(97)00174-0","article-title":"Calcium sensitisers: mechanisms of action and potential usefulness as inotropes","volume":"36","author":"Lee","year":"1997","journal-title":"Cardiovasc Res"},{"key":"B19","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s00395-018-0671-4","article-title":"Cardioprotective effect of ghrelin against myocardial infarction-induced left ventricular injury via inhibition of SOCS3 and activation of JAK2\/STAT3 signaling","volume":"113","author":"Eid","year":"2018","journal-title":"Basic Res Cardiol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1161\/HYPERTENSIONAHA.114.04864","article-title":"Endogenous ghrelin attenuates pressure overload-induced cardiac hypertrophy via a cholinergic anti-inflammatory pathway","volume":"65","author":"Mao","year":"2015","journal-title":"Hypertens Dallas Tex 1979"},{"key":"B21","doi-asserted-by":"publisher","first-page":"H426","DOI":"10.1152\/ajpheart.00643.2007","article-title":"Ghrelin suppresses cardiac sympathetic activity and prevents early left ventricular remodeling in rats with myocardial infarction","volume":"294","author":"Soeki","year":"2008","journal-title":"Am J Physiol-Heart Circ PhysioL"},{"key":"B22","doi-asserted-by":"publisher","first-page":"696138","DOI":"10.3389\/fcvm.2021.696138","article-title":"Inotrope use and intensive care unit mortality in patients with cardiogenic shock: an analysis of a large electronic intensive care unit database","volume":"8","author":"Gao","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"B23","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1002\/ehf2.14580","article-title":"Acyl ghrelin increases cardiac output while preserving right ventricular-pulmonary arterial coupling in heart failure","volume":"11","author":"Erhardsson","year":"2024","journal-title":"ESC Heart Fail"},{"key":"B24","doi-asserted-by":"publisher","first-page":"e24308","DOI":"10.1002\/clc.24308","article-title":"Right ventricular-pulmonary arterial coupling and outcome in heart failure with preserved ejection fraction","volume":"47","author":"Wang","year":"2024","journal-title":"Clin Cardiol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"e1054","DOI":"10.1161\/CIR.0000000000000490","article-title":"Role of biomarkers for the prevention, assessment, and management of heart failure: a scientific statement from the American Heart Association","volume":"135","author":"Chow","year":"2017","journal-title":"Circulation"},{"key":"B26","doi-asserted-by":"publisher","first-page":"3674","DOI":"10.1161\/01.CIR.0000149746.62908.BB","article-title":"Effects of ghrelin administration on left ventricular function, exercise capacity, and muscle wasting in patients with chronic heart failure","volume":"110","author":"Nagaya","year":"2004","journal-title":"Circulation"},{"key":"B27","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1210\/js.2017-00433","article-title":"Changes in the cardiac GHSR1a-Ghrelin system correlate with myocardial dysfunction in diabetic cardiomyopathy in mice","volume":"2","author":"Sullivan","year":"2017","journal-title":"J Endocr Soc"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.2147\/CIA.S259889","article-title":"The additional prognostic value of Ghrelin for mortality and readmission in elderly patients with acute heart failure","volume":"15","author":"Yuan","year":"2020","journal-title":"Clin Interv Aging"},{"key":"B29","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.arcmed.2014.01.004","article-title":"Prognostic value of plasma ghrelin in predicting the outcome of patients with chronic heart failure","volume":"45","author":"Chen","year":"2014","journal-title":"Arch Med Res"},{"key":"B30","doi-asserted-by":"publisher","first-page":"225","DOI":"10.3343\/alm.2023.43.3.225","article-title":"Biomarkers in heart failure: from research to clinical practice","volume":"43","author":"Berezin","year":"2023","journal-title":"Ann Lab Med"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.3390\/cells11061039","article-title":"Interconnection between cardiac cachexia and heart failure-protective role of cardiac obesity","volume":"11","author":"Soto","year":"2022","journal-title":"Cells"},{"key":"B32","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.hfc.2019.08.006","article-title":"Cardiac cachexia revisited: the role of wasting in heart failure","volume":"16","author":"Valentova","year":"2020","journal-title":"Heart Fail Clin"},{"key":"B33","doi-asserted-by":"publisher","first-page":"2034","DOI":"10.1161\/hc4201.097836","article-title":"Elevated circulating level of ghrelin in cachexia associated with chronic heart failure: relationships between ghrelin and anabolic\/catabolic factors","volume":"104","author":"Nagaya","year":"2001","journal-title":"Circulation"},{"key":"B34","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1093\/eurjhf\/hfp088","article-title":"Ghrelin resistance occurs in severe heart failure and resolves after heart transplantation","volume":"11","author":"Lund","year":"2009","journal-title":"Eur J Heart Fail"},{"key":"B35","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1097\/MED.0b013e3283469505","article-title":"Hormonal consequences and prognosis of chronic heart failure","volume":"18","author":"Attanasio","year":"2011","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/HPC.0000000000000004","article-title":"Patient selection for advanced heart failure therapy referral","volume":"13","author":"Fanaroff","year":"2014","journal-title":"Crit Pathw Cardiol"}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2025.1574521\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T05:28:43Z","timestamp":1751606923000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2025.1574521\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,4]]},"references-count":36,"alternative-id":["10.3389\/fcvm.2025.1574521"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2025.1574521","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,4]]}}}